VaginalCancer News


VaginalCancer News

Lymphoseek® Results from Phase 3 Clinical Trial in Oral Cavity Cancer of the Head and Neck (March 4, 2015)

CancerConnect News: Navidea Biopharmaceuticals, Inc. (NYSE MKT:  NAVB), recently announced the peer-reviewed publication of results from a Phase 3 clinical trial of Lymphoseek® (technetium 99m tilmanocept)... Continue Reading

National Multiple Myeloma Awareness Month on CancerConnect (March 3, 2015)

Sun Valley, ID & Fort Worth, TX– OMNI Health Media (OMNI) announces the launch of multiple myeloma educational programs for national multiple myeloma awareness month. As the month of March brings... Continue Reading

Lenvatinib; First Promising Treatment for Refractory Thyroid Cancer Patients in Years (March 3, 2015)

CancerConnect News: In a pivotal Phase III study published in the New England Journal of Medicine, the oral anti-angiogenic therapy lenvatinib appears to be a very promising new treatment for patients... Continue Reading

What’s New in the Management of Lymphoma? (March 2, 2015)

What’s New in the Management of Lymphoma? Cancers that begin in cells of the lymph system are referred to as malignant lymphomas. Lymphomas range from aggressive to slow growing or indolent and can be... Continue Reading

Palbociclib/Letrozole Improves Outcomes of Estrogen Receptor–Positive/HER2-Negative Advanced Breast Cancer (February 27, 2015)

The results of the phase II PALOMA-1/TRIO-18 trial were recently reported in The Lancet Oncology and suggest that the addition of Ibrance® (palbociclib) to Femara® (letrozole) delayed the time to cancer... Continue Reading

More VaginalCancer News

Latest VaginalCancer News By Stage

CancerConnect Cancer Commuity & Discussions

Cancer Types

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS